Patents by Inventor Qingmei ZHANG

Qingmei ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11220533
    Abstract: An sDR5-Fc recombinant fusion protein having amino acid sequence of SEQ ID NO: 2 and a gene encoding the protein and having a nucleotide sequence as shown in SEQ ID NO: 1 are provided. Further, applications of the protein and the gene in the preparation of medicament for preventing and treating autoimmune hepatitis or drug-induced liver injury are provided.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: January 11, 2022
    Assignee: SHENZHEN ZHONGKE AMSHENN PHARMACEUTICAL CO., LTD.
    Inventors: Xiaochun Wan, Junxin Li, Qian Chen, Qingmei Zhang
  • Publication number: 20190352354
    Abstract: An sDR5-Fc recombinant fusion protein having amino acid sequence of SEQ ID NO: 2 and a gene encoding the protein and having a nucleotide sequence as shown in SEQ ID NO: 1 are provided. Further, applications of the protein and the gene in the preparation of medicament for preventing and treating autoimmune hepatitis or drug-induced liver injury are provided.
    Type: Application
    Filed: July 11, 2016
    Publication date: November 21, 2019
    Applicant: SHENZHEN ZHONGKE AMSHENN PHARMACEUTICAL CO., LTD.
    Inventors: Xiaochun WAN, Junxin LI, Qian CHEN, Qingmei ZHANG
  • Patent number: D938352
    Type: Grant
    Filed: November 23, 2020
    Date of Patent: December 14, 2021
    Inventor: Qingmei Zhang